Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast

Rhea-AI Summary

Intra-Cellular Therapies (Nasdaq: ITCI) announced a conference call on March 1, 2022, at 8:30 a.m. ET to discuss its corporate updates and financial results for the year ending December 31, 2021. To participate, dial 1-(844) 835-6563 or 1-(970) 315-3916 internationally, using conference ID 5899935. The presentation will be available live and archived in the Investor Relations section on their website. Founded on Nobel prize-winning research, Intra-Cellular focuses on innovative treatments for CNS disorders.

Positive

• Upcoming conference call to discuss 2021 financial results may provide insights into company performance.
• Company leverages Nobel prize-winning research for developing treatments.

Negative

• None.

NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Tuesday, March 1, 2022, to provide a corporate update and discuss details of the Company's financial results for the quarter and year ended December 31, 2021.

To access the live conference call via phone, dial 1-(844) 835-6563. The international dial-in number is 1-(970) 315-3916. The conference ID number for the live call is 5899935.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.

Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
cradinovic@burnsmc.com
212-213-0006 

FAQ

When will Intra-Cellular Therapies discuss its financial results for 2021?

Intra-Cellular Therapies will discuss its financial results for 2021 during a conference call on March 1, 2022.

How can I access the Intra-Cellular Therapies conference call?

You can access the conference call by dialing 1-(844) 835-6563 or 1-(970) 315-3916 for international callers, using the conference ID 5899935.

What is Intra-Cellular Therapies focused on?

Intra-Cellular Therapies focuses on developing therapeutics for central nervous system disorders.

Where can I find the archived webcast of the conference call?

The archived webcast will be available in the 'Events & Presentations' section of Intra-Cellular Therapies' Investor Relations webpage.